MHB3TM

  • Evaluation of MHB3TM on Cartilage Loss / Knee Instability
    In a chondro-protection study the effect of Baxyl®'s MHB3TM formulation was dramatic, preventing the progression of osteoarthritis into articular cartilage and preventing the formation of osteophytes (bone spurs) as well.

    Adobe PDF Document>> Read More

  • Evaluation of MHB3TM on the Development of Osteopenia
    In a recent bone loss study the effects of oral MHB3TM (modified hyaluronan) supplementation on bone loss were investigated and found that MHB3TM significantly reduces the development of osteopenia associated with estrogen depletion.

    Adobe PDF Document>> Read More

  • Effects of MHB3TM on Cartilage Loss / Monoarthritis
    In a disease modification study the benefits of Baxyl's MHB3TM were evaluated against existing osteoarthritis where it proved to have disease modifying benefits.

    Adobe PDF Document>> Read More

  • Evaluation of MHB3TM among Patients with Chronic Joint Symptoms
    In a Chronic Joint Symptoms study the effect of Baxyl's MHB3TM formulation relieves joint pain and inflammation contributing to an improved range of motion and an increase in daily activity among the majority of subjects.

    Adobe PDF Document >> Read More


Copyright ® 2010 Cogent Solutions Group, LLC. All rights reserved. | P.O. Box 11686 · Lexington, Kentucky 40577 · Toll Free: 888-521-8867 |  Privacy · Contact Us · About Cogent